Floatz logo

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter

Ovarian Mucinous Adenocarcinoma

Mayo Clinicgene_therapyPhase 2Active
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Ovarian Mucinous Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
Ohio State University Comprehensive Cancer Center
Phase 3BBB
CIS-DIAMMINEDICHLOROPLATINUM II
Ohio State University Comprehensive Cancer Center
Phase 3BB
Cyclophosphamide
Roswell Park Cancer Institute
Phase 2B
Inno-206
National Cancer Institute (NCI)
Phase 2B
Pembrolizumab
Roswell Park Cancer Institute
Phase 2B

View all 17 →

Same molecule, other indications

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter is also rated in:

primary peritoneal carcinomaDormant
B
Indicative ·
63 / 100
View asset →
fallopian tube serous adenocarcinomaDormant
B
Indicative ·
59 / 100
View asset →
fallopian tube mucinous adenocarcinomaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →